6.
Langfelder P, Horvath S
. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559.
PMC: 2631488.
DOI: 10.1186/1471-2105-9-559.
View
7.
Ko C, McNiff J, Glusac E
. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi). J Cutan Pathol. 2009; 36(10):1063-8.
DOI: 10.1111/j.1600-0560.2008.01221.x.
View
8.
Patro R, Duggal G, Love M, Irizarry R, Kingsford C
. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017; 14(4):417-419.
PMC: 5600148.
DOI: 10.1038/nmeth.4197.
View
9.
Saunders C, Wong W, Swamy S, Becq J, Murray L, Cheetham R
. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012; 28(14):1811-7.
DOI: 10.1093/bioinformatics/bts271.
View
10.
Karakas C, Giampoli E, Love T, Hicks D, Velez M
. Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation. Diagn Pathol. 2024; 19(1):10.
PMC: 10777531.
DOI: 10.1186/s13000-023-01426-5.
View
11.
Bastian B, Leboit P, Pinkel D
. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000; 157(3):967-72.
PMC: 1885704.
DOI: 10.1016/S0002-9440(10)64609-3.
View
12.
Garg M, Couturier D, Nsengimana J, Fonseca N, Wongchenko M, Yan Y
. Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nat Commun. 2021; 12(1):1137.
PMC: 7893180.
DOI: 10.1038/s41467-021-21207-2.
View
13.
Roy S, Gerami P, Busam K
. Malignant melanoma test results by a commercial 35-gene expression test are enriched for benign or atypical Spitz tumors. J Cutan Pathol. 2022; 49(12):1009-1011.
DOI: 10.1111/cup.14312.
View
14.
Donati M, Nosek D, Waldenback P, Martinek P, Jonsson B, Galgonkova P
. MAP2K1-Mutated Melanocytic Neoplasms With a SPARK-Like Morphology. Am J Dermatopathol. 2020; 43(6):412-417.
DOI: 10.1097/DAD.0000000000001840.
View
15.
Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I
. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014; 5:3116.
PMC: 4084638.
DOI: 10.1038/ncomms4116.
View
16.
Zhang A, Rush P, Tsao H, Duncan L
. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors. J Cutan Pathol. 2019; 46(12):965-972.
DOI: 10.1111/cup.13530.
View
17.
Langmead B, Trapnell C, Pop M, Salzberg S
. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25.
PMC: 2690996.
DOI: 10.1186/gb-2009-10-3-r25.
View
18.
Fumero-Velazquez M, Hagstrom M, Dhillon S, Geraminejad T, Olivares S, Donati M
. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1. Am J Surg Pathol. 2023; 47(12):1438-1448.
DOI: 10.1097/PAS.0000000000002131.
View
19.
Chatzopoulos K, Syrnioti A, Linos K
. Spitz Melanocytic Tumors: A Fascinating 75-Year Journey. Genes (Basel). 2024; 15(2).
PMC: 10887813.
DOI: 10.3390/genes15020195.
View
20.
Haberecker M, Topfer A, Melega F, Moch H, Pauli C
. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types. Histopathology. 2023; 82(7):1003-1012.
DOI: 10.1111/his.14884.
View